Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration (FDA) for marketing. more
| Time Frame | BBP | S&P500 |
|---|---|---|
| 1-Week Return | -2.78% | 1.4% |
| 1-Month Return | -3.17% | 1.17% |
| 3-Month Return | 4.06% | 3.14% |
| 6-Month Return | 23.46% | 17.61% |
| 1-Year Return | 44.26% | 15.37% |
| 3-Year Return | 110.03% | 80.54% |
| 5-Year Return | 109.61% | 78.16% |
| 10-Year Return | 213.79% | 259.41% |
| Time Frame | BBP | S&P500 |
|---|---|---|
| 1-Week Return | -77.01% | 106.46% |
| 1-Month Return | -32.42% | 15.20% |
| 3-Month Return | 17.52% | 13.36% |
| 6-Month Return | 53.32% | 38.95% |
| 1-Year Return | 44.26% | 15.37% |
| 3-Year Return | 28.06% | 21.77% |
| 5-Year Return | 15.95% | 12.24% |
| 10-Year Return | 12.12% | 13.65% |
| Stock name | Ticker | Weight |
|---|---|---|
Moderna Inc | MRNA | 4.96% |
Iovance Biotherapeutics Inc | IOVA | 4.57% |
Omeros Corp | OMER | 2.77% |
Verastem Inc | VSTM | 2.52% |
Precigen Inc | PGEN | 2.42% |
Halozyme Therapeutics Inc | HALO | 2.01% |
Zai Lab Ltd | ZLAB | 1.96% |
Kiniksa Pharmaceuticals International Plc | KNSA | 1.9% |
Rigel Pharmaceuticals Inc | RIGL | 1.87% |
Xeris Biopharma Holdings Inc | XERS | 1.78% |
BeOne Medicines Ltd | BGNE | 1.78% |
ImmunityBio Inc | IBRX | 1.71% |
Protagonist Therapeutics Inc | PTGX | 1.66% |
Tarsus Pharmaceuticals Inc | TARS | 1.59% |
ADMA Biologics Inc | ADMA | 1.58% |
Regeneron Pharmaceuticals Inc | REGN | 1.57% |
Novavax Inc | NVAX | 1.56% |
Ligand Pharmaceuticals Inc | LGND | 1.55% |
Roivant Sciences Ltd | ROIV | 1.55% |
Kura Oncology Inc | KURA | 1.54% |
Gilead Sciences Inc | GILD | 1.54% |
Harmony Biosciences Holdings Inc | HRMY | 1.5% |
Sarepta Therapeutics Inc | SRPT | 1.5% |
Amgen Inc | AMGN | 1.5% |
Vertex Pharmaceuticals Inc | VRTX | 1.49% |
Zymeworks Inc | ZYME | 1.49% |
Nuvation Bio Inc | NUVB | 1.48% |
Biogen Inc | BIIB | 1.46% |
CRISPR Therapeutics AG | CRSP | 1.46% |
Insmed Inc | INSM | 1.45% |
Agios Pharmaceuticals Inc | AGIO | 1.44% |
Travere Therapeutics Inc | TVTX | 1.43% |
Exelixis Inc | EXEL | 1.43% |
TG Therapeutics Inc | TGTX | 1.42% |
Incyte Corp | INCY | 1.41% |
BioNTech SE | BNTX | 1.4% |
Rhythm Pharmaceuticals Inc | RYTM | 1.38% |
Immunocore Holdings PLC | IMCR | 1.38% |
Geron Corp | GERN | 1.38% |
United Therapeutics Corp | UTHR | 1.37% |
BioMarin Pharmaceutical Inc | BMRN | 1.37% |
Ascendis Pharma A/S | ASND | 1.36% |
Madrigal Pharmaceuticals Inc | MDGL | 1.36% |
Arcutis Biotherapeutics Inc | ARQT | 1.36% |
Ironwood Pharmaceuticals Inc | IRWD | 1.35% |
Krystal Biotech Inc | KRYS | 1.34% |
Aurinia Pharmaceuticals Inc | AUPH | 1.32% |
Bridgebio Pharma Inc | BBIO | 1.31% |
Syndax Pharmaceuticals Inc | SNDX | 1.31% |
Denali Therapeutics Inc | DNLI | 1.24% |
ACADIA Pharmaceuticals Inc | ACAD | 1.23% |
Cytokinetics Inc | CYTK | 1.22% |
BioCryst Pharmaceuticals Inc | BCRX | 1.22% |
Neurocrine Biosciences Inc | NBIX | 1.15% |
Arrowhead Pharmaceuticals Inc | ARWR | 1.14% |
PTC Therapeutics Inc | PTCT | 1.12% |
Mirum Pharmaceuticals Inc | MIRM | 1.11% |
Alnylam Pharmaceuticals Inc | ALNY | 1.07% |
Axsome Therapeutics Inc | AXSM | 0.93% |
Phathom Pharmaceuticals Inc | PHAT | 0.89% |
Ultragenyx Pharmaceutical Inc | RARE | 0.79% |
Ionis Pharmaceuticals Inc | IONS | 0.79% |
Ardelyx Inc | ARDX | 0.78% |
Legend Biotech Corp | LEGN | 0.71% |
Liquidia Corp | LQDA | 0.51% |
Cash/Cash equivalents | Cash.Cash.equivalents | 0.25% |
OmniAb Inc | OmniAb.Inc | 0% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
Virtus LifeSci Biotech Products ETF (BBP) share price today is $100.9666.
Yes, Indians can buy shares of Virtus LifeSci Biotech Products ETF (BBP) on Vested. To buy BBP from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Virtus LifeSci Biotech Products ETF (BBP) on Vested. You can start investing in Virtus LifeSci Biotech Products ETF (BBP) with a minimum investment of $1.
The 52-week high price of Virtus LifeSci Biotech Products ETF (BBP) is $110.05. The 52-week low price of Virtus LifeSci Biotech Products ETF (BBP) is $70.27.
The stock symbol (or ticker) of Virtus LifeSci Biotech Products ETF is BBP.
Yes, you can setup SIP in Virtus LifeSci Biotech Products ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of BBP on the Vested app.
The expense ratio of Virtus LifeSci Biotech Products ETF (BBP) is 0.79%.
Link copied